SEATTLE — A Washington lawmaker has announced plans to introduce legislation that would cap insulin costs at $100 a month.
State Sen. Karen Keiser introduced the bill last month after a report showed patients have spent three times more on insulin increasing from $231 to $736 between 2002 and 2013, KING-TV reported Thursday.
The measure mandates that health plans issued or renewed on or after Jan. 1, 2021 must cap insulin copayments, deductibles and other forms of cost sharing at $100 for each 30-day supply, officials said.
Keiser also introduced multiple other bills in December that target increasing medication costs including one creating a cost monitoring board and another creating a work group to look at allowing a single statewide insulin purchaser, officials said.
The legislative session is scheduled to begin Jan. 14.
Colorado capped insulin prices last month at $100 a month and Illinois approved a similar cap in November, officials said.